ACTIVE Investigators (2009). Effect of clopidogrel
added to aspirin in patients with atrial fibrillation. New England Journal of Medicine, 360(20): 2066-2078.
Boos CJ, et al. (2008). Atrial fibrillation (chronic),
search date August 2007. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.
Calkins H, et al. (2007). HRS/EHRA/ECAS Expert
consensus statement on catheter and surgical ablation of atrial fibrillation:
Recommendations for personnel, policy, procedures, and follow-up. A report of
the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of
Atrial Fibrillation. Heart Rhythm, 4(6):
Dronedarone (Multaq) for atrial fibrillation (2009). Medical Letter on Drugs and Therapeutics, 51(1322): 78-79.
Fuster V, et al. (2006). ACC/AHA/ESC 2006 guidelines
for the management of patients with atrial fibrillation-Executive summary. A
report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines and the European Society of Cardiology Committee
for Practice Guidelines (Writing committee to revise the 2001 guidelines for
the management of patients with atrial fibrillation). Circulation, 114(7): 700-752. [Erratum in Circulation, 116(6): e137.]
Hirsch J, et al. (2008). Executive summary: American
College of Chest Physicians evidence-based clinical practice guidelines (8th
ed.). Chest, 133(6): 71S-109S.
Lip GYH, Watson T (2008). Atrial fibrillation (acute
onset), search date October 2007. Online version of BMJ Clinical Evidence:
Mozaffarian D, et al. (2008). Physical activity and
incidence of atrial fibrillation in older adults. The Cardiovascular Health
Study. Circulation. Published online August 4, 2008
Prystowsky EN, Waldo AL (2008). Atrial fibrillation,
atrial flutter, and atrial tachycardia. In V Fuster et al., eds.,
Hurst's the Heart, 12th ed., pp.953-982. New York:
Roux, J-F, et al. (2009). Antiarrhythmics after ablation of atrial fibrillation (5A study). Circulation, 120(12): 1036-1040.
Roy D, et al. (2008). Rhythm control versus rate
control for atrial fibrillation and heart failure. New England Journal of Medicine, 358(25): 2667-2677.
Shea JB, Sears SF (2008). A patient's guide to living
with atrial fibrillation. Circulation, 117(20):
Sherman DG, et al. (2005). Occurrence and
characteristics of stroke events in the atrial fibrillation follow-up
investigation of sinus rhythm management (AFFIRM) study. Archives of Internal Medicine, 165(10): 1185-1191.
Smith SC, et al. (2006). AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute.
Circulation, 113(19): 2363-2372. [Erratum in
Circulation, 113(22): 847.]
Snow V, et al. (2003). Management of newly detected
atrial fibrillation: A clinical practice guideline from the American Academy of
Family Physicians and the American College of Physicians. Annals of Internal Medicine, 139(12): 1009-1018.
Treatment of atrial fibrillation (2010). Treatment Guidelines From The Medical Letter, 8(97): 65-70.
Van Gelder IC, et al. (2010). Lenient versus strict rate control in patients with atrial fibrillation. New England Journal of Medicine, 362(15): 1363-1373.
Wang TJ, et al. (2003). A risk score for predicting
stroke or death in individuals with new-onset atrial fibrillation in the
community: The Framingham heart study. JAMA, 290(8):
Wann LS, et al. (2011). 2011 ACCF/AHA/HRS Focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123(1): 104-123.
Wann LS, et al. (2011). 2011 ACCF/AHA/HRS focused updated on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123(10): 1144-1150.
Wilkoff BL, et al. (2008). HRS/EHRA expert consensus
on the monitoring of cardiovascular implantable electronic devices (CIEDS):
Description of techniques, indications, personnel, frequency and ethical
considerations. Heart Rhythm, 5(6): 907-925. Available